“Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension.” Mark Toshner, Colin Church, Lars Harbaum, et al. Eur Respir J 2022; 59: 2002463.
医学
药品
孟德尔遗传
内科学
心脏病学
肺动脉高压
药理学
生物
遗传学
基因
出处
期刊:The European respiratory journal [European Respiratory Society] 日期:2022-07-01卷期号:60 (1): 2052463-2052463